PharmaShots

JUNE 28, 2023

In July 2002, Amgen acquired the rights to Enbrel as part of its acquisition of Immunex. Some of the alternative drugs for Enbrel include: Enbrel’s Biosimilars6 As Enbrel has a long journey in the market it is already facing competition from biosimilars in the US and other countries. and Canada. Enbrel Prescribing Information 3.

Biosimilars 40

Biosimilars Insurance Coverage and Processing Dosage Compounding 40

PharmaShots

MARCH 29, 2023

Some companies accept the offered period and open doors to biological drugs or biosimilars. Though the exact working of Actemra in the body is not known, from early research, it is suggested that Actemra blocks the connecting of IL-6 protein to the cells and prevents overactivity of the immune system.

Biosimilars 49

Biosimilars Diabetes Chemotherapy Immunity 49

Big Molecule Watch

APRIL 30, 2025

collectively, “Alexion”) alleging Alexion “violated antitrust law by monopolistic acts that unlawfully delayed the introduction of biosimilar competition for eculizumab. . (“Emblem”) filed a class action suit in the District Court for the District of Massachusetts against Alexion Pharmaceuticals, Inc.

Biosimilars 52

Biosimilars Immunization Immunity 52